The Affiliated Hospital of Nanjing university Medical School

Nanjing

1 studies enrolling now · 1 studies all time

What they study most

Hepatocellular Carcinoma (HCC)

Studies at this site

• Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma — Recruiting now